Compare Costco Wholesale Corporation (COST) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Costco Wholesale Corporation vs Zimmer Biomet Holdings Inc — how do they compare? Costco Wholesale Corporation trades at $945.58 (market cap $420.05B), while Zimmer Biomet Holdings Inc trades at $88.96 (market cap $16.95B). The key difference: Costco Wholesale Corporation is far larger — about 24.8× Zimmer Biomet Holdings Inc's market cap, and Zimmer Biomet Holdings Inc pays the higher dividend (1.08%). Which is the better fit depends on your goals — on Pluang, investors hold Costco Wholesale Corporation for 132 Days and Zimmer Biomet Holdings Inc for 89 Days on average.
| COST | ZBH | |
|---|---|---|
Market Cap | $420.05B | $16.95B |
Volume | 2,087,565 | 2,505,240 |
Sector | Consumer Staples | Health |
52-Week High | $1.09K | $103.98 |
52-Week Low | $849.63 | $79.58 |
Typical Hold Time | 132 Days | 89 Days |
Enterprise Value | $407.33B | $24.02B |
Dividend Yield | 0.62% | 1.08% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Costco (COST) trades at $942.25, up 0.7% on the day, showing strong operational momentum with a 28.4% ROE and 11.3% March sales growth. The stock is near its 52-week high, supported by bullish moving averages, though RSI levels indicate potential overbought conditions. Recent membership fee hikes and robust cash flow generation underscore its resilient business model.
Outlook remains positive given analyst consensus and a $1,090 price target, but elevated P/E of 45.66 poses valuation risk. Key catalysts include sustained membership growth and expansion, while risks involve competitive pressures and macroeconomic sensitivity.
Zimmer Biomet (ZBH) trades at $88.49, down 1.33% today, with a bearish technical signal from moving averages. The company reported strong earnings beats in recent quarters, with Q2 2026 EPS of $2.07 surpassing the $2.01 estimate. Revenue growth is steady, reaching $8.23B in 2025, though net income margin has moderated to 9.48%. A quarterly dividend of $0.24 was declared, payable in October 2026. Analyst consensus price target is $103.11, implying potential upside from current levels.
The outlook is mixed: solid fundamentals and earnings momentum support long-term value, but technical weakness and elevated debt levels pose near-term risks. Investment appeal hinges on execution of commercial transformation and robotics adoption offsetting competitive pressures. Key risks include margin compression and macroeconomic sensitivity affecting procedure volumes.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Costco Wholesale Corporation
The leading warehouse club, Costco has 815 stores worldwide (at the end of fiscal 2021), with most sales derived in the United States (72%) and Canada (14%). It sells memberships that allow customers to shop in its warehouses, which feature low prices on a limited product assortment. Costco mainly caters to individual shoppers, but roughly 20% of paid members carry business memberships. Food and sundries accounted for 40% of fiscal 2021 sales, with non-food merchandise 29%, warehouse ancillary and other businesses (such as fuel and pharmacy) nearly 17%, and fresh food 14%. Costco's warehouses average around 146,000 square feet
Read more on COST →About Zimmer Biomet Holdings Inc
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →
